Search Results

You are looking at 11 - 20 of 89 items for :

  • "celiac disease" x
  • All content x
Clear All

De Nitto, D., Monteleone, I., Franzè, E. és mtsai: Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World. J. Gastroenterol., 2009, 37 , 4609

Restricted access

sensitive detection of coeliac disease toxic prolamins. Analytica Chimica Acta 551 :105–114. O’sullivan C.K. Monoclonal antibody-based competitive assay for the sensitive detection of

Restricted access
Orvosi Hetilap
Authors: Anna Körner, Péter Tóth-Heyn, Antal Dezsőfi, Gábor Veres, László Madácsy, and András Arató

405 Paulsen, G., Lundin, K. E., Gjertsen, H. A. és mtsai: HLA DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of aminoacid

Restricted access

References 1 Parzanese I, Qehajaj D, Patrinicola F, et al. Celiac disease: from pathophysiology to treatment. World J Gastrointest Pathophysiol. 2017; 8: 27

Open access
Orvosi Hetilap
Authors: Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, Andrea Péter, and Katalin Dankó

–472. Henriksson, K. G., Hallert, C., Walan, A.: Letter: Gluten-sensitive polymyositis and enteropathy. Lancet, 1976, 2(7980), 317. Henriksson, K. G., Hallert, C., Norrby, K., et al.: Polymyositis and adult coeliac disease

Restricted access

Cellier, C., Delabesse, E., Helmer, C. és mtsai: Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet, 2000, 356 , 203

Restricted access
Acta Alimentaria
Authors: F. Békés, K. Ács, Gy. Gell, Cs. Lantos, A-M. Kovács, Zs. Birinyi, and J. Pauk

. Anderson , R.P. , Degano , P. , Godkin , A.J. , Jewell , D.P. & Hill , A.V.S. ( 2000 ): In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A gliadin T-cell epitope

Open access

.J.K., Kosma, V-M., Maki, M., Heikkinen, M. & Uusitupa, M.I.J. (2002): No harm from five year ingestion of oats in coeliac disease. Gut , 50 , 332–335. Uusitupa M.I.J. No harm

Restricted access

. [Hungarian] 8 Lionetti E, Catassi C. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol. 2011; 30: 219

Restricted access

prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018; 16: 823–836.e2. 17 Fedor I, Zöld É, Barta Zs. The

Open access